Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease
NCT: NCT07324161 · RECRUITING
Brief Summary
This study is grounded in the regulatory mechanisms of the glymphatic system and applies repetitive transcranial magnetic stimulation (rTMS) to the treatment of Alzheimer's disease (AD). The clinical efficacy and safety of rTMS will be systematically evaluated. Furthermore, transcranial magnetic stimulation-evoked potentials (TMS-EEG) and functional near-infrared spectroscopy (fNIRS) will be employed to investigate, from the perspectives of synaptic plasticity and neurovascular coupling, the mechanisms by which rTMS influences glymphatic function. Collectively, this work aims to provide new insights into both the therapeutic effectiveness and the underlying mechanisms of rTMS in AD.
Frequently Asked Questions
What is Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease?
Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease is a clinical trial registered under NCT07324161. Current status: RECRUITING.
What is the status of NCT07324161?
The current status of NCT07324161 (Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease) is: RECRUITING.
When did Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease start?
Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease started on 2025-04-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.